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Glycosylphosphatidylinositol (GPI) anchoring is a common, relevant posttranslational modiﬁcation
of eukaryotic surface proteins. Here, we developed a fast, simple, and highly sensitive (high
attomole-low femtomole range) method that uses liquid chromatography-tandem mass spectro-
metry (LC-MS
n) for the ﬁrst large-scale analysis of GPI-anchored molecules (i.e., the GPIome) of a
eukaryote, Trypanosoma cruzi, the etiologic agent of Chagas disease. Our genome-wise prediction
analysis revealed that approximately 12% of T. cruzi genes possibly encode GPI-anchored proteins.
By analyzing the GPIome of T. cruzi insect-dwelling epimastigote stage using LC-MS
n, we identiﬁed
90 GPI species, of which 79 were novel. Moreover, we determined that mucins coded by the T. cruzi
small mucin-like gene (TcSMUG S) family are the major GPI-anchored proteins expressed on the
epimastigote cell surface. TcSMUG S mucin mature sequences are short (56–85 amino acids) and
highly O-glycosylated, and contain few proteolytic sites, therefore, less likely susceptible to
proteases of themidgut ofthe insect vector. Weproposethat ourapproach could be used forthe high
throughput GPIomic analysis of other lower and higher eukaryotes.
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Introduction
Glycosylphosphatidylinositol (GPI) anchoring is a ubiquitous
posttranslational modiﬁcation (PTM) of proteins in lower and
higher eukaryotes (McConville and Ferguson, 1993). In
mammals, GPI biosynthesis is vital for embryonic develop-
ment, and GPI-anchored proteins participate in important
biological processes such as cell–cell interactions, signal
transduction, endocytosis, complement regulation, and anti-
genic presentation (McConville and Ferguson, 1993; Orlean
and Menon, 2007; Paulick and Bertozzi, 2008). In lower
eukaryotes, particularly yeast and protozoa, GPI-anchored
molecules have also been shown to have important biological
functions (Ferguson, 1999; McConville and Menon, 2000;
Orlean and Menon, 2007). In pathogenic protozoan parasites
(e.g., Trypanosoma cruzi, Trypanosoma brucei, Leishmania
major, and Plasmodium falciparum), for instance, GPI-
anchored glycoconjugates may extensively coat the plasma
membrane and are involved in many aspects of host–parasite
interactions, such as adhesion and invasion of host cells,
modulation and evasion from host immune response, and
pathogenesis (McConville and Ferguson, 1993; Ferguson,
1999; McConville and Menon, 2000; Buscaglia et al, 2006;
Gazzinelli and Denkers, 2006; Acosta-Serrano et al, 2007).
In T. brucei, the GPI biosynthesis has already been validated
as a molecular target for development of new drugs against
Africansleepingsickness(Smithetal,2004).ToexploitGPIsas
targets for the development of new therapies against other
endemic protozoa (e.g., T. cruzi, P. falciparum, Leishmania
spp.), a detailed, large-scale analysis of the GPI-anchored
molecules expressed on the cell surface of these parasites (i.e.,
the GPIome) is of paramount importance. However, one of the
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spatial expression of GPI-anchored molecules in eukaryotic
cells is the dearth of a universal and straightforward approach
for GPI analysis (Ferguson, 1992; Hooper, 2001). The difﬁculty
to develop a universal method to analyze GPI and GPI-
anchored proteins may be due to their complex structure.
The general structure of a GPI anchor comprises a lipid
tail containing either a phosphatidylinositol (PI) or an
inositolphosphorylceramide(IPC)moiety,attachedtoaglycan
core consisting of a glucosamine (GlcN) residue followed by
threemannose(Man)residues.InthethirdMandistalfromthe
GlcN residue, usually an ethanolaminephosphate (EtNP)
group attaches the GPI to the C-terminus of the protein.
Further modiﬁcations in the anchor may occur, such as extra
glycan, EtNP and/or aminoethylphosphonate (AEP) residues
substituting the glycan core, and/or an extra fatty acid (acyl)
group attached to the myo-inositol ring, increasing the
complexity of the GPI structure (Ferguson, 1999; McConville
and Ferguson, 1993). Owing to their complex structure
and amphiphilic nature, GPIs and GPI-anchored proteins are
somewhat difﬁcult to be extracted, puriﬁed, and fully
characterized.
Elortza et al (2003) applied an approach to release GPI-
anchored proteins from the plasma membrane by treatment
with PI-speciﬁc phospholipases. Enzyme-treated and control
samples were then separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and the
differential bands were excised and analyzed by mass
spectrometry (MS) (Elortza et al, 2003). Although this
approach proved to be valuable in identifying GPI-anchored
proteins, it did not provide any information on the GPI anchor
structure itself. Another useful but somewhat limited ap-
proach is the extraction of GPI-anchored proteins with neutral
detergents or 9% aqueous (aq.) n-butanol and further
puriﬁcation byhydrophobicinteraction (HIC) or reversephase
chromatography (RPC) (Ferguson, 1992; Hooper, 2001). Both
HIC and RPC methods separate biomolecules according to
differences in their hydrophobicity. However, in contrast to
RPC,HICuses less denaturingbuffersand/ororganicsolvents,
and higher initial salt concentration to enhance the hydro-
phobic interactions between the biomolecule and the chro-
matography medium (stationary phase). On the other hand,
RPC medium is generally more hydrophobic than that of a HIC
medium, leading to stronger, more selective interactions
between the biomolecule and the medium, and successful
elution is achieved by the use of increasing concentration of
organic solvent. A major drawback is that most stationary
phases used for HIC and RPC have amphiphilic nature (i.e.,
hydrophobic groups attached to hydrophilic beads) and,
therefore, their resolution is rather low. This might be due to
the interaction of the resin with both hydrophobic (lipid)
and hydrophilic (glycan) moieties of the GPI. Thus,
here we hypothesize that the use of a more hydrophobic,
polystyrene-divinylbenzene-based resin for RPC (e.g., POROS
R1) (DePhillips et al, 1994; Whitney et al, 1998) could result in
a much stronger, more selective interaction between the GPI
lipidmoietyandthecovalentlyattachedfunctionalgroup(e.g.,
C4) of the stationary phase. This could considerably enhance
the resolution of the process of puriﬁcation of GPI-anchored
molecules and free GPIs.
T. cruzi is the etiologic agent of Chagas disease or American
trypanosomiasis, a neglected tropical disease that affects over
11 million people and causes an estimated 50000 annual
deaths in Latin America (Dias et al, 2002; Barrett et al, 2003;
Moncayo and Ortiz Yanine, 2006). Lately, Chagas disease has
become a public health threat for the US and European
countries like Spain, where an increasing number of chroni-
cally T. cruzi-infected migrants from endemic countries are
residing in (Bern et al, 2007; Piron et al, 2008). There are only
two commercial drugs (Benznidazole and Nifurtimox) avail-
able for the treatment of Chagas disease, and both are partially
effectiveandhighlytoxic.Inaddition,anincreasingnumberof
drug-resistant T. cruzi strains have been reported (Urbina and
Docampo, 2003; Wilkinson et al, 2008). Moreover, thus far no
human vaccine is available for treating or preventing Chagas
disease (Garg and Bhatia, 2005; Dumonteil, 2007; Hotez et al,
2008). Therefore, there is an urgent need for new therapeutic
targets against T. cruzi.
T. cruzi has four developmental stages or forms, two
(i.e., epimastigote and metacyclic trypomastigote) dwelling
in the triatomine insect vector, and two (i.e., amastigote and
trypomastigote) in the mammalian host. The parasite can be
transmitted by the bloodsucking insect vector (a Reduviidae,
popularly known as the kissing bug), blood transfusion, organ
transplantation, or congenitally. The vector-mediated trans-
mission begins when metacyclic trypomastigotes present in
the vector’s excrement enter the host bloodstream through the
insect’s bite wound or exposed mucosal tissues. Metacyclic
forms immediately invade a wide range of nucleated cells and
transform into proliferative amastigote forms, which divide by
binary ﬁssion and, 4–5 days later, transform into intracellular
trypomastigote forms. These forms rupture the cell membrane
and invade other surrounding cells, or enter the bloodstream
to infect remote organs or tissues, or eventually another insect
vector (Barrett et al, 2003).
T. cruzi GPI-anchored proteins are expressed in all develop-
mental stages and encoded by thousands of members of
multigene families, such as trans-sialidase (TS)/gp85 glyco-
protein,mucin,mucin-associatedsurfaceprotein(MASP),and
metalloproteinasegp63.Someoftheseproteins(e.g.,TS/gp85,
mucins) have been shown to be essential for the infectivity of
the parasite or its escape from the host immune response
(Frasch,2000;Acosta-Serranoetal,2001,2007;Buscagliaetal,
2006; Yoshida, 2006; Alves and Colli, 2008). In addition, GPI
anchors from T. cruzi were shown to be strong proinﬂamma-
tory molecules, being critical in the modulation of the
host immune response against this parasite (Almeida and
Gazzinelli, 2001; Gazzinelli and Denkers, 2006). Thus, GPI-
anchored proteins and GPI anchors themselves seem to be
very attractive targets for new therapies against Chagas
disease.
Nowwereportthe ﬁrstlarge-scaleanalysisof the GPIome of
a eukaryote, T. cruzi. Initially, we carried out a GPI-anchoring
prediction analysis for all protein-encoding genes of the T.
cruzi genome. Next, we developed a polystyrene-based
(POROS R1) RPC to purify protein-free GPIs (glycoinositolpho-
spholipids, GIPLs) and GPI-anchored proteins. This chromato-
graphic step was then coupled to tandem MS, and used for the
analysis of GIPLs and proteinase-released GPIs. Our results
show that the GPIome of T. cruzi is much more complex than
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biosynthesisofT.cruziGPIanchors,whichcouldbeeventually
exploited as potential therapeutic target in Chagas disease.
Results
Genome-wise prediction of GPI-anchored proteins
from T. cruzi
To estimate the extent of T. cruzi proteins that might be GPI
anchored, we performed a prediction analysis using the
FragAnchor algorithm (Poisson et al, 2007). Proteins that will
undergo GPI PTM contain a short hydrophobic C-terminal
sequence that is removed before the en bloc addition of the
complete GPI anchor by the transamidase complex (McCon-
ville and Ferguson, 1993; Ferguson, 1999). The newly formed
C-terminal amino acid receiving the GPI is known as the o
(omega) site. The FragAnchor algorithm, thus, predicts
the GPI-anchoring sites based on the short hydrophobic
C-terminal amino acid sequence and the o site. To test the
sensitivity and accuracy of the prediction analysis, we used a
database set containing all sequences of the T. cruzi mucin II
(TcMUC II) family. This family of glycoproteins had their
GPI-anchoring sites experimentally validated (Buscaglia et al,
2004) and, thus, could be used as the training set for our
analysis. Out of 624 TcMUC II sequences, 598 (95.8%) were
highly probable to be GPI anchored (Table I), showing that the
sensitivity of the prediction is likely high. Next, to test the
accuracy of the prediction, we removed a short hydrophobic
sequence comprising the last 20 amino-acid residues at the C-
terminus of the sequences and analyzed them with the
FragAnchoralgorithm.Withthisapproachonlytwosequences
(0.3%) were wrongly predicted to be GPI anchored (Table I),
so the prediction could be considered very accurate.
The prediction analysis using the genome sequences
(TcruziDB v5.0) lead to the estimation that 11.9% of the
sequences have potential GPI-anchoring site (Table I). By
performing the analysis using the T. cruzi sequences deposited
on the GenBank, 11.7% of the sequences were predicted to be
GPI anchored (Table I). Of those predicted GPI-anchored
proteins, the members of MASP (1730 sequences), mucin
(1262 sequences), and TS/gp85 (1160 sequences) multigene
families were the most abundant among the sequences
deposited in the GenBank. Amastin, gp63, mucin-like, and
TolT were also represented by multiple sequences (Table I).
TolT is an immunogenic surface protein found on T. cruzi
trypomastigotes (Quanquin et al, 1999) with protein sequence
identity and biochemical and biological traits in common with
the bacterial TolA proteins, which are part of the Tol system
of most gram-negative bacteria and are involved in the outer
membrane stability (Lazzaroni et al, 2002). Taken together,
our GPI-anchoring prediction data indicates that a high
proportion of the T. cruzi genes possibly encode GPI-anchored
proteins.
Implementing a polystyrene-based RPC to purify
free and protein-linked GPIs
Next, we developed a polystyrene-based RPC and tested it
using a synthetic GPI (Yashunsky et al, 2006) containing
several by-products resulting from unsaturated fatty acid
oxidation or removal during its prolonged storage as nuclear
magnetic resonance (NMR) sample in [
2H]6-DMSO solution.
The GPI sample was loaded onto a ziptip manufactured with
POROS R1 resin (C4 groups linked to polystyrene-divinylben-
zene beads) and eluted step-wisely with increasing(40,50,60,
and 70%) 2-propanol concentrations. Each fraction was then
analyzed by negative-ion mode electrospray ionization (ESI)-
MS (Materials and methods). The results clearly showed an
efﬁcient separation between the bona ﬁde GPI species and
lyso-GPIs, oxidized GPIs, and other by-products (Figure 1).
Then, we tested the suitability and efﬁciency of POROS R1
for the puriﬁcation of GPI-anchored proteins. We analyzed an
organic (9% n-butanol) extract enriched with GPI-anchored
proteins from epimastigote forms of T. cruzi (Almeida et al,
Table I Genome-wise prediction of putative GPI-anchored protein sequences in
T. cruzi
Database Number of
sequences
Highly probable
GPI-anchored
sequences
% Total
TcruziDB v5.0 19613 2304 11.9
GenBank T. cruzi
sequences
41478 4941 11.7
GeneDB TcMUC II
sequences
624 598 95.8
GeneDB TcMUC
II
 20AA sequences
a
624 2 0.3
Classiﬁcation of the predicted T. cruzi GPI-anchored proteins from
GenBank
Protein family Highly probable
GPI-anchored
sequences
% Total
potentially
GPI-anchored
proteins
MASP (mucin-associated proteins) 1730 35.0
Mucins 1262 25.5
TcMUC I 100 2.0
TcMUC II 1126 22.8
TcMUC III 2 0.0
TcSMUG S 20 0.4
TcSMUG L 14 0.3
TS/gp85 glycoproteins 1160 23.5
trans-Sialidase 1102 22.3
gp90 22 0.4
gp82 15 0.3
Complement regulatory protein 9 0.2
Tc85/gp85 8 0.2
Flagellum-associated protein 3 0.1
SAPA 1 0.0
Other families 789 16.0
Amastin 216 4.4
gp63 143 2.9
Mucin-like 86 1.7
TolT 14 0.3
Hypothetical proteins 207 4.2
Others 123 2.5
Total 4941 100
aThese sequences had 20 amino-acid residues from the C-terminal removed
before the GPI prediction analysis, and served as negative controls for the
prediction.
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of biotin-labeled epimastigote mucins, and fractionated in a
solid-phase extraction cartridge prepared with POROS R1
resin. The fractions were then monitored by SDS–PAGE and
chemiluminescent assay (CLA) (Figure 2A). By CLA, the
epimastigote mucins were shown to be eluted mainly with
22.5% aq. n-propanol (Figure 2B). Consistently with this
result, the silver-stained gel showed two broad bands in the
34–67kDa rangewith typical behavior of epimastigote mucins
(Acosta-Serranoetal,2001; Buscagliaetal,2006) (bands9and
10, Supplementary Figure 1). These bands were excised,
digested with trypsin, and sequenced by liquid chromatogra-
phy (LC) coupled to MS
2. As expected, here we were unable to
detect any peptide sequence, most probably because (1)
epimastigote mucins are highly glycosylated (Acosta-Serrano
et al, 2001; Buscaglia et al, 2006), and (2) their protein core
seems almost completely resistant to different proteases (e.g.,
trypsin and proteinase K) (Almeida et al, unpublished
observation). We have observed earlier that on trypsin
treatment,epimastigotemucinsonlyslightlyshifttheirrelative
migration on SDS–PAGE, suggesting that small peptide
fragment(s) is(are) removed from the protein backbone
(Almeida et al, unpublished observation). We have also
reported that epimastigote mucins are only partially degraded
by proteinase K, releasing the intact GPI anchor previously
linked to their C-terminal end (Almeida et al, 2000).
To further corroborate the presence of GPI-anchored
proteins, the fraction eluted from the POROS R1 column with
22.5% aq. n-propanol was digested with proteinase K and
analyzed by negative ion-mode ESI-MS. We could detect at
least four ion species with m/z identical to puriﬁed eMUC-
derived GPIs (eMUC-GPIs) (Previato et al, 1995; Serrano et al,
1995; Almeida et al, 2000) that were further conﬁrmed by
fragmentation analysis (Figure 2C and D). Taken together, our
results validate the use of POROS R1 for the puriﬁcation of free
GPIs and GPI-anchored proteins.
Analysis of protein-free GPIs by LC-MS
n
To ultimately increase the sensitivity and the speed of our
analysis, we packed a nanocapillary column with POROS R1
resin and coupled it to an LC-MS system. Then, we performed
LC-MS
2 and LC-MS
3 analysis of organic (91% n-butanol, and
combined chloroform/methanol and chloroform/methanol/
water) extracts enriched for GIPLs (Figure 3A). GPIs are
frequentlyanalyzedinnegative-ionmodeESI-MS, dissolvedin
100 798.37
797 90
lyso-GPI
Oxidized GPIs
Other by-products 
0
797.90
850.44
798.87
849.92
809.41
810.35
820.40 842.29
954.44 850.85
953.94
861.35 883.43
862.39
902.35 929.52
921.89
953.46
955.46
965.93
1006.47 981.54 1019.47
798 37
ESI-
2.15e3
ESI
lyso-GPI + Na Starting material
lyso-GPI
Oxidized GPIs
GPI
0
100
%
798.37
797.90 850.37 798.87
849.89
809.38
810.35
838.40
850.88
883.46
861.39
862.39
954.48 902.38 913.45 965.46
ESI-
1.36e4
40% 2-propanol lyso-GPI + Na
[GPI + 3O 2H]2−
100
%
954.44
953.94
929.49
902.38 861.42 850.40
798.44 883.50 913.37
953.46
954.99
955.46
965.97
1006.44 966.96 994.52 1017.48
1031.04
ESI-
8.88e3
50% 2-propanol
[GPI + 3O – 2H]2
[GPI + 3O – 3H + Na]2−
100
%
0
929.49
928.95
798.40
767 38 850 40 809.48 883 43 861.42 902 42 915 87
929.95
930.45
940.50
954.48
947.98 981.47 994.63 1005.99
ESI-
1.86e3
60% 2-propanol
R
e
l
a
t
i
v
e
 
a
b
u
n
d
a
n
c
e
[GPI – 3H + Na]2−
[GPI – 2H]2−
[GPI – 3H + K]2−
100
%
0
767.38 850.40 809.48 883.43 86 902.42 915.87
929.49
928.98
929.99
930.45940.46
941.54 994 52 954.44
981 50 1006 06
ESI-
1.59e3
70% 2-propanol
[GPI – 2H]2−
[GPI – 3H + Na]2−
[GPI – 3H + K]2−
760 780 800 820 840 860 880 900 920 940 960 980 1000 1020 1040
0
883.46 798.34
767.45
850.40 809.41 841.61 861.46 902.42 915.87
994.52 981.50 1006.06
1046.5 1022.55
m/z
%
Figure 1 Fractionation of the synthetic trypomastigote mucin GPI and by-products using POROS R1 ziptip. The synthetic mucin GPI (Man-[EtNP]Man-Man2-
[AEP]GlcN-InsP-1-O-alkyl-C16:0-2-O-acyl-C18:2-Gro) was puriﬁed through POROS R1 50 resin as described in Materials and methods. The top panel represents the
MS spectrum of the starting material, whereas the bottom four panels represent the MS spectra of the ziptip fractions eluted with 40, 50, 60, and 70% 2-propanol,
respectively. All observed GPI species are doubly charged, plus or minus sodium adduct. lyso-GPI, GPI species missing the C18:2-fatty acid at C-2 of the glycerol
backbone; m/z, mass-to-charge ratio.
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conditions, the silica tubing has negative charges, which
interact with amine (GlcN, AEP, and/or EtNP) groups present
in the GPI. To neutralize the negative charge of the silica
tubing,weanalyzedourGPIsamplesinpositive-ionmodeESI-
MS, in the presence of 0.2% formic acid (FA), used as the ion
pair for the LC-MS analysis. With the LC-MS approach, we
could detect and characterize at least 78 doubly charged ion
species of GIPLs (Table II; Supplementary Table I; Supplemen-
tary Figure 2A–C). Of those, 70 were found to be novel species
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Figure 2 Puriﬁcation of GPI-anchored proteins from T. cruzi epimastigotes using POROS R1 50 cartridge. (A) Schematic representation of the methodology used for
the puriﬁcation and analysis of GPI-anchored proteins. Brieﬂy, epimastigote cells were delipidated with chloroform/methanol (1:1, v/v), followed by chloroform/methanol/
water (1:2:0.8, v/v/v). Then, GPIs were extracted with 9% n-butanol and partitioned with n-butanol/water solution. The aqueous phase, rich in GPI-anchored proteins,
was spiked with biotinylated epimastigote mucins (biotin-eMUC), puriﬁed in an octyl-Sepharose column. The GPI-rich extract was fractionated in a POROS R1 50 solid-
phase extraction cartridge and the eluted fractions were analyzed by chemiluminescent assay (CLA) and SDS–PAGE, or digested with proteinase K and analyzed by
electrospray ionization-tandem mass spectrometry (ESI-MS/MS). (B) CLA of POROS R1 50 fractions. Biotin-eMUC, biotinylated epimastigote mucins. (C) The fraction
elutedwith22.5%n-propanol(equivalentto2.7 10
7epimastigotecells)wasdigestedwithproteinaseK,puriﬁedinaPOROSR150ziptip,andanalyzedinnegative-ion
mode using an ESI-QTOF-MS (Micromass Qtof-1, Waters). The top panel represents the MS spectrum of the puriﬁed epimastigote mucin (p-eMUC-GPI) fraction,
whereas the bottom panel is the MS spectrum of the synthetic T. cruzi epimastigote mucin GPI (s-eMUC-GPI) (Man-[EtNP]Man-Man2-GlcN[AEP]-InsP-1-O-C16:0-alkyl-
2-O-C16:0-acyl-Gro)(Yashunskyetal,2006).TheasteriskindicatesanotherspeciesofGPI,previouslycharacterizedas[AEP]Man4-GlcN[AEP]-InsP-1-O-alkyl-C16:0-2-
O-acyl-C16:0-Gro (Almeida et al, 2000). (D) ESI-QTOF-MS
2 spectrum of parent ion at m/z 917.0. The top panel represents the MS
2 spectrum of the puriﬁed T. cruzi
epimastigote mucin GPIs (p-eMUC-GPIs), whereas the bottom panel represents the MS
2 spectrum of the synthetic eMUC-GPI (s-eMUC-GPI) puriﬁed by POROS R1.
Noteworthily, the same ion species are observed in both spectra, conﬁrming the assignment of the major parent ion at m/z 917.03 in (C). AAG, alkylacylglycerol; AEP,
aminoethylphosphonate; Alk, alkyl; Gro, glycerol; GroP, 3-O-phosphoglycerol; Hex, hexose; HexN, hexosamine; Ins, myo-inositol; InsP, myo-inositolphosphate;
M, molecular mass; m/z, mass-to-charge ratio; PI, phosphatidylinositol.
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for GIPLs obtained by either extraction procedure (9%
n-butanol or combined chloroform/methanol and chloroform/
methanol/water) (Figure 3A) clearly indicate that the majority
(92–98%) of GIPLs contain ceramide (Cer) and only a small
fraction (2–8%) have alkylacylglycerol (AAG) in the lipid
moiety (Table II). In MS
2, typically the fragmentation (colli-
sion-induced dissociation, CID) of the doubly charged GIPL
parent-ion gave rise to fragment- or daughter-ions correspond-
ing to the loss of Cer ([M CerþH]
þ), and to a series of ions
containing AEP or EtNP residue attached to multiple (n¼1–5)
hexose (Hex) residues (e.g., Supplementary Figure 2C3, 2C5,
2C7, and 2C9). On the other hand, fragment-ions correspond-
ing to the neutral loss of Hex residue(s) and AEP or EtNP were
also highly abundant. We could also ﬁnd a fragment
corresponding to the inositolphosphate (InsP) attached to
AEP-HexN (AEP-HexN-InsP) at m/z 529.3 (e.g., Supplemen-
tary Figure 2C3, 2C5, 2C7, and 2C9). Interestingly, some
species had only one AEP residue and no EtNP. In these
species, the AEP residue could be attached to either a Hex or
HexN residue. For instance, the fragmentation of the GIPL
species AEP-Hex6-HexN-InsP-C16:0/d18:0-Cer observed at m/z
1012.49 showed diagnostic fragment ions corresponding to the
AEP-HexN attached to IPC (AEP-HexN-IPC) (m/z 1050.48) and
Hex2-AEP (m/z 432.22) (Supplementary Figure 2C22).
Still in the case of ceramide-containing GIPLs, the two
most abundant daughter-ions observed by MS
2 analysis
were the one resulting from the neutral loss of ceramide
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þ) and the dehydrated ceramide moiety itself
([Cer H2OþH]
þ) (Supplementary Figure 2C3). Thus, to
obtain more detail of the ceramide moiety, we performed
MS
3 analysis of the two most abundant ions resulting from the
loss of H2O (at m/z 520.56 and 502.49). The ion species at m/z
520.56 gave rise to a C16:0-1-azirine derivative at m/z 280.24
and a dehydrated sphingoid (d18:1)-base derivative at m/z
264.41 (Hsu and Turk, 2000) (Supplementary Figure 2C4).
1-Azirine fatty acid derivatives were also frequent in MS
2
spectra(e.g., Supplementary Figure 2C3, 2C7, 2C9, and 2C12),
thus, the structure of many ceramides could be determined
without the need of MS
3 analysis. Most of the ceramides were
dihydroxylated, but some of them had three hydroxyl groups
instead (Table II; Supplementary Table I). The sphingoid base
was invariably d18:0, d18:1, or d18:2, whereas the fatty acid
varied in length from C16:0 to C26:0. Surprisingly, we found a
few ceramide species containing odd-carbon number fatty
acids (OCFAs), such as C23:0 and C25:0 (e.g., species 31, 33,
36, 40, 47, 60, 62–64, 66, and 67; Supplementary Table I).
Interestingly, OCFAs have been described earlier in T. cruzi
neutral glycosphingolipids (Barreto-Bergter et al, 1992). Other
trypanosomatids, such as Phytomonas and Herpetomonas,
have also been reported to biosynthesize de novo a range of
iso-branched C18, C20, and C22 polyunsaturated fatty acids
(Fish et al, 1982). In our case, wecould not determine whether
the observed OCFAs were linear or methyl-branched, or both.
Furthermore, considering the calculated monoisotopic mole-
cular mass, we cannot exclude the possibility that these fatty
acids are actually oxidized C22:1 and C24:1 species. However,
owing to their late retention time in the RPC (Supplementary
Table I), more likely these fatty acids are OCFAs. Further
studies are necessary to conﬁrm the existence and precise
structure of these unusual fatty acid species in T. cruzi.
AfewGIPLspeciescontainingAAGasthelipidtailwerealso
found (Table II; Supplementary Table I; Supplementary
Figure 2A and B). Unlike the ceramide-containing GIPLs,
MS
2 analysis of AAG-containing GIPL species revealed that
fragments derived from the lipid tail were not always the most
abundant ones (Supplementary Figure 2C25, 27–35). There-
fore, we could not carryout data-dependent MS
3 analysisof all
AAG-containing GIPL species. Trying to circumvent this issue,
we performed data-independent MS
3 analysis by selecting the
most abundant and frequent lipid moiety-derived ion species
observed at m/z 537.6 (Supplementary Figure 2C27–30).
Again, we observed that fragment ions derived from the AAG
moiety had very low abundance and we could not obtain
enough information to determine the ﬁne composition of the
lipid tail (data not shown). Thus, we annotated the less
abundant AAG-containing GIPL species (e.g., C34:0-AAG,
C34:1-AAG, C34:2-AAG, and C42:1-AAG) with the total
number of carbons instead (Table II; Supplementary Table I).
However, as in T. cruzi GPIs all 1-O-alkyl chains thus far
described are C16:0 (Serrano et al, 1995; Carreira et al, 1996;
Almeida et al, 2000; Previato et al, 2004), it is most likely that
most if not all AAG-containing GIPL species observed in this
study would have the same C16:0-alkyl chain composition.
TorelativelyquantifytheGIPLspecies,weexploitedtheMS
2
total-ion chromatogram (MS
2 TIC) approach (Asara et al,
2008) (Materials and methods, and below). The quantiﬁcation
revealed that GIPL species containing ceramide (91.6–97.9%)
are much more abundant than those having AAG (2.1–8.4%)
as lipid tail (Table II; Supplementary Table I; Supplementary
Figure 2).
Analysis of proteinase K-released GPIs by LC-MS
n
Next, the fraction rich in GPI-anchored proteins was digested
with proteinase K and analyzed by LC-MS
2 and LC-MS
3
(Figure 3A). Proteinase K has a broad range of speciﬁcity
and cleaves at the carboxyl terminus of the polypeptide,
thus ensuing GPIs that are free of amino-acid residues
(Almeida et al, 2000). The fragmentation pattern of proteinase
K-released GPIs was very similar to that of the GIPLs
(Figure 3C–E; Supplementary Figure 3). In fact, some of the
AAG-containing GPIs had the same glycan and lipid structure
as some of the GIPLs (Table II). Thus, we cannot discard the
possibility that these AAG-containing GIPLs could be actually
direct precursorsof GPI anchorsto be attached to proteins. It is
also worth pointing out that all GPI structures derived from
GPI-anchored proteins had AAG as the lipid moiety. Con-
versely, the majority (91.4–97.8%) of GIPLs had ceramide as
the lipid tail (Table II; Supplementary Table I). It still remains
to be determined why epimastigotes, in contrast to metacyclic
trypomastigotes (Serrano et al, 1995), do not express
ceramide-containing GPI anchors in their major surface
glycoproteins(e.g.,mucins). Furthermore,wecould not detect
any major GIPL species in the proteinase K-released GPI
analysis, indicating that the sample was free of these
glycolipids. The major fragments from MS
3 analysis of AAG
were the ones resulting from the loss of either alkyl or acyl
group. Noteworthily, all AAG structureswe could determine had
286
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at the sn-2 position (Figure 3C–E; Supplementary Figure 3).
In total, 11 species of GPI anchors were identiﬁed. Of those,
only three had been described earlier (Previato et al, 1995;
Serrano et al, 1995; Almeida et al, 2000) and nine were found
to be novel but much less abundant species (Figure 3B;
Table II; Supplementary Table I; Supplementary Figure 3). The
MS
2 TIC quantiﬁcation showed that the two major species
[EtNP]Hex4-[AEP]HexN-InsP-alkyl-C16:0-acyl-C16:0-Gro;
[AEP]Hex4-[AEP]HexN-InsP-alkyl-C16:0-acyl-C16:0-Gro)
compriseabout95%oftotalprotein-derivedGPIs,whereasthe
least abundant species accounts for only 0.04% ([EtNP]Hex4-
[AEP]HexN-InsP-alkylacyl-C42:1-Gro)(SupplementaryTableI).
The MS
2 and MS
3 spectra, and schematic fragmentation for
Table II Summary of glycan, lipid, and peptide composition of the GPIome of T. cruzi epimastigotes characterized by LC-MS/MS
Overall data GPI-anchored molecule (origin or treatment)
a
GIPLs (CM and CMW) GIPLs (BuOH) Proteins (Proteinase K) Proteins (Trypsin)
Inositol content (picomoles per 1e7 cells) 889.95±49.02
b 9.17±1.51 0.43±0.002 0.43±0.002
Number of MS
2 spectra 1162 196 54 25
Number of identiﬁed species 70 44 11 5
Relative quantiﬁcation by MS2 TIC (% total)
c
Glycan moiety
[AEP]Hex4-[AEP]HexN-InsP — — 14.31 11.43
[AEP]Hex5-[AEP]HexN-InsP 17.61 46.24 — 3.82
[AEP]Hex6-[AEP]HexN-InsP 0.16 1.16 — —
[EtNP]Hex4-[AEP]HexN-InsP 0.12 0.01 83.97 56.50
[EtNP]Hex5-[AEP]HexN-InsP 26.68 35.47 1.36 19.93
[EtNP]Hex6-[AEP]HexN-InsP 0.09 0.17 0.18 —
[EtNP]Hex4-HexN-InsP — — 0.19 8.31
[AEP]Hex4-HexN-InsP or Hex4-[AEP]HexN-InsP 1.31 0.16 — —
[AEP]Hex5-HexN-InsP or Hex5-[AEP]HexN-InsP 0.03 — — —
[AEP]Hex6-HexN-InsP or Hex6-[AEP]HexN-InsP 52.03 14.72 ——
Hex7-[AEP]HexN-InsP 0.81 0.59 — —
Hex8-[AEP]HexN-InsP 1.13 1.48 — —
Hex7-HexN-InsP 0.03 — — —
NANA-Hex7-[AEP]HexN-InsP 0.01 — — —
Total 100.00 100.00 100.00 100.00
Lipid moiety
Alkyl-C16:0-acyl-C16:0-Gro 7.48 2.12 96.24 91.69
Alkylacyl-C33:0-Gro — — 0.18 —
Alkylacyl-C34-Gro 0.15 0.08 0.80 —
Alkylacyl-C34:1-Gro 0.66 — — —
Alkylacyl-C34:2-Gro 0.22 — 0.25 8.31
Alkyl-C16:0-acyl-C24:0-Gro 0.13 — 2.49 —
Alkylacyl-C42:1-Gro — — 0.04 —
C16:0/d18:0-Cer 21.67 4.80 — —
C16:0/d18:1-Cer 26.00 11.29 ——
C16:0/t18:0-Cer 0.30 — — —
C22:0/d18:0-Cer — 0.64 — —
C22:0/d18:1-Cer 0.01 0.08 — —
C22:0/t18:1-Cer 0.23 — — —
C23:0/d18:0-Cer 0.10 — — —
C23:0/d18:1-Cer 0.21 0.75 — —
C24:0/d18:0-Cer 19.21 26.11 ——
C24:0/d18:1-Cer 21.09 48.84 ——
C24:0/d18:2-Cer 0.12 0.16 — —
C24:0/t18:0-Cer 0.05 0.14 — —
C24:0/t18:1-Cer — 1.14 — —
C25:0/d18:0-Cer 0.42 0.39 — —
C25:0/d18:1-Cer 0.52 1.31 — —
C26:0/d18:0-Cer 0.64 0.92 — —
C26:0/d18:1-Cer 0.79 1.22 — —
Total 100.00 100.00 100.00 100.00
Peptide
APTPGD — — — 100.00
aCM and CMW, CHCl3:MeOH (1:1, v/v) and CHCl3:MeOH:water (1:2:0.8, v/v/v), respectively; BuOH, 1-butanol.
bThe amount of GIPL-derived myo-inositol is overestimated because of the presence of large quantities of free phosphatidylinositol (PI) in this fraction.
cThe most abundant (410%) glycan or lipid structures are shown in bold italics.
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C16:0-acyl-C24:0-Gro),representingB2.5%ofthetotalprotein-
derived GPI anchors, is shown in Figure 3C–E.
Analysis of trypsin-released GPI-peptides by
LC-MS
n
In T. cruzi, mucins are one of the major GPI-anchored antigens
expressed on the parasite cell surface, and theyare involved in
the escape from host immune response as well as adhesion
and invasion of host cells (Acosta-Serrano et al, 2001;
Buscaglia et al, 2006; Acosta-Serrano et al, 2007). T. cruzi
mucins are encoded by at least 863 genes, grouped in two
major families (i.e., TcMUC and TcSMUG) (Buscaglia et al,
2006; Acosta-Serrano et al, 2007). We had shown earlier that
we could identify the mucins expressed by the infective
trypomastigote stage through the analysis of a short (3–4-mer)
peptide containing the o site still attached to the GPI anchor
(GPI-peptide) (Buscaglia et al, 2004). Here, we exploited this
approach to sequence the GPI-peptide derived from mucins of
noninfective epimastigotes and, therefore, to determine which
gene family(ies) is(are) expressed on this parasite stage.
Although epimastigote mucins are somewhat resistant to
different proteases (e.g., trypsin, proteinase K) as observed by
SDS–PAGE (not shown), the C-terminal region seemstobe less
glycosylated, thus, susceptible to proteolytic digestion. Thus,
the mucin-rich (9% n-butanol) extract from T. cruzi epimas-
tigotes was digested with trypsin and analyzed by LC-MS
2 and
LC-MS
3 (Figure 3A). On the basis of the structures identiﬁed
fromtheproteinase K-treatedsamples,wecould rapidly match
several fragments, such as AAG (m/z 537.6), AEP-HexN-PI
(m/z 1065.5), Hex(AEP)HexN-PI (m/z 1227.6), and Hex2(AE-
P)HexN-PI (m/z 1389.7), thus partially determining the GPI-
peptide structure (Figure 4A). By combining the partially
determined GPI-structure and the possible peptides that could
be generated by tryptic digestion and being attached to a GPI
anchor (using the GPI-anchoring prediction), one peptide
candidate could be the APTPGD sequence from mucin
TcSMUG S. Indeed, the fragmentation of GPI-peptide species
showed abundant fragments corresponding to the mass of this
peptide attached to dehydrated EtN, EtNP, or EtNP-Hex1–4
(Figure 4A), similar to the fragmentation pattern described
elsewhere (Redman et al, 1994). However, the fragmentation
of the peptide moiety in the MS
2 was very poor impairing the
sequence conﬁrmation. To ultimately sequence the peptide
and determine the o site, fragments corresponding to the
peptide attached to dehydrated EtN or AEP were subjected to
data-independent MS
3 analysis (Figure 4B; Supplementary
Figure 4). The quality of MS
3 spectra were good enough to
enable the de novo sequencing of the peptide. With this
approach, we could sequence peptides attached to ﬁve
different GPI structures, four of them also detected after
proteinase K digestion (Figure 4A–C; Table II; Supplementary
Table I; Supplementary Figure 4). Although ﬁve GPI species
werefound,allthesespecieswereattachedtothesamepeptide
sequence (APTPGD), which corresponds to the carboxyl
terminus of the TcSMUG S subfamily of mucins from T. cruzi
(El-Sayed et al, 2005; Buscaglia et al, 2006; Acosta-Serrano
et al, 2007). This result was corroborated by amino-acid
compositional analysis (not shown). The TcSMUG S subfamily
comprises eight unique sequences (GenBank accession
numbers XP_804663.1, XP_807370.1, XP_807371.1,
XP_821038.1, XP_821039.1, XP_821040.1, XP_821041.1, and
XP_821042.1), with predicted mature protein sequences
varying from 56 to 85 amino acids. TcSMUG S sequences
contain approximately 40% threonine in their composition
(Buscaglia et al, 2004), suggesting that they could be heavily
O-glycosylated and, therefore, quite resistant to protease
digestion as we have already observed (data not shown).
Quantitative analysis of GPIs
The absolute quantiﬁcation was done by analyzing the myo-
inositol content of the samples (Materials and methods). As
most of the identiﬁed GPIs have closely related structures and
conserved ionizable groups (AEP, EtNP, GlcN, and phos-
phate), we speculated that their ionization efﬁciency by
electrospray would be comparable. Thus, we would be able
to relatively quantify the different species by the signal
intensity of each GPI or GIPL species. First, we injected the
synthetic GPIsGPI-C16:0 mixedwith anequalamountofsGPI-
C18:1 or sGPI-C18:2 (see Materials and methods for details).
Although these GPI species have different lipid tails, their
ionization efﬁciencies were almost identical (Supplementary
Figure 5A and B). Next, we analyzed sample mixtures
containing constant concentration of sGPI-C18:1 (5mM),
but variable concentration of sGPI-C16:0 (0.005–5mM). The
response in the MS was evaluated by comparing the signal
intensities of the parent-ion or by MS
2 TIC approach
(Asara et al, 2008). The quantiﬁcation by comparing parent-
ionsignalintensitiesshowedsmallerrors(1.3–33.6%),butthe
responsewaslinearonlyfrom1:1to1:20ratio(Supplementary
Table II). On the other hand, we observed higher errors (9.5–
48.2%) by MS
2 TIC approach, similar to the ones described
by Asara et al (2008), but the linear response was shown to be
much broader (from 1:1 to 1:500 ratio) (Supplementary Table
II). As most of the identiﬁed GPI and GIPL species are poorly
abundant, we decided to relatively quantify them by MS
2 TIC
approach.
Combining both quantiﬁcations, we were also able to
estimate absolute amounts of individual protein-derived GPI
and GIPL species. To determine the sensitivity of our method,
weperformedLC-MS
2analysiswithdifferentamountsofGPIs.
First, we performed the analysis in a data-dependent acquisi-
tion (DDA) mode, fragmenting the ﬁve most abundant ions
with dynamic exclusion. We detected GPIs from as low as
5 10
5 parasites, equivalent to 21.5 femtomoles of total GPIs
and 3.1 femtomoles for the least abundant species, as
quantiﬁed by myo-inositol analysis by GC-MS (data not
shown). Furthermore, MS spectra were also collected by
multiple-reaction monitoring (MRM) mode, targeting the two
major species of proteinase K-released GPIs at m/z 911.42
and 919.23 (Supplementary Table I). With this approach, we
detected and characterized GPIs from as low as 1 10
5
parasites, equivalent to 4.3 femtomoles of total GPIs and 611
attomoles for the least abundant species observed (Figure 5A
and B). It is also worth to point out that epimastigote is much
smaller compared with higher eukaryote cells. Thus, our
method would require less number of mammalian cells for
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GPI-anchor structure from T. brucei transferrin-receptor using
19.7 picomoles(MehlertandFerguson, 2008). Thus, our LC-MS
approachis fromB6000- (for DDA) to B30000-fold (forMRM)
more sensitive than current nonradioactive methods.
Retention times and column separation
The retention time of GPI species was determined as described
in Materials and methods. Notably, the retention times of
protein-derived GPIs and GIPLs containing the same lipid tail
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Figure 4 Analysis by LC-MS
2 and LC-MS
3 of GPI-peptides released by trypsin treatment. (A) MS2 spectrum of the GPI-peptide species at m/z 1188.5, which
corresponds to APTPGD-EtNP-Hex4-[AEP]HexN-InsP-1-O-alkyl-C16:0-2-O-acyl-C16:0-Gro. (B) MS3 spectrum of the fragment corresponding to the peptide attached
to dehydrated EtN at m/z 582.4. The peptide fragments are indicated. (C) Proposed fragmentation and structure of the GPI-peptide APTPGD-EtNP-Hex4-[AEP]HexN-
InsP-1-O-alkyl-C16:0-2-O-acyl-C16:0-Gro. APTPGD, Ala-Pro-Thr-Pro-Gly-Asp.
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no correlation with the size and different substituent groups
(e.g., EtNP, AEP, Hex) attached to the glycan core. This ﬁnding
indicates that the separation is likely given by the exclusive
interaction of the lipid tail with the hydrophobic polystyrene-
divinylbenzene-based C4 (POROS R1) resin. As expected,
we also noticed that protein-derived GPIs and GIPLs with
shorter, hydroxylated, and/or unsaturated lipid tails were
eluted ﬁrstfromthecolumn,comparedwith thosewith longer,
nonhydroxylated, and/or saturated lipid tails (Supplementary
Table I).
Discussion
Here, we present the ﬁrst global analysis of GPI-anchored
molecules from a human pathogenic eukaryote, T. cruzi. Our
analysisincludedthegenome-wisepredictionofGPI-anchored
proteins and the large-scale structural determination of
protein-free and protein-linked GPIs. The prediction analysis
showed that about 12% of T. cruzi genes possibly encode GPI-
anchored proteins. This number is much higher compared
with the African sleep sickness parasite, T. brucei (strain
TREU927), which has only 132 (1.5%) of the 8750 sequences
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Figure 5 Analysis by LC-MRM-MS of proteinase K-released GPIs from T. cruzi epimastigotes. The two major GPI species originally observed at m/z 918.93 and
910.93 (protein-derived GPI species 1 and 2, respectively; Supplementary Table I) were subjected to MRM analysis (A) Extracted-ion chromatogram of the diagnostic
ions corresponding to the dehydrated alkylacylglycerol (AAG—H20) ion-species at m/z 537.5, andthe loss of alkylacylglycerol (M—AAG) at m/z 1300.1 and1284.1. The
peak detected at the retention time 30.93min includes the two GPI species. For this experiment, the equivalent of 10
5 cells, corresponding to 4.3 femtomoles of total
GPIs, was used. (B)M S
2 spectrum of the major GPI species ([EtNP]Hex4-[AEP]HexN-InsP-1-O-alkyl-C16:0-2-O-acyl-C16:0-Gro) at m/z 919.
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performed GPI-anchoring prediction for several organisms,
including other early divergent eukaryotes Plasmodium
falciparum (0.19%) and Leishmania major (1.02%); yeasts,
Saccharomyces cerevisiae (0.95%) and Cryptococcus neofor-
mans (0.90%); plants, Arabidopsis thaliana (0.83%) and
Gibberella zeae (1.13%); and mammals, human (0.74%), and
mouse (0.82%). Our study clearly shows that the number of
potential GPI-anchored sequences is much higher in T. cruzi
than in any other studied organisms.
The GPI-anchoring sequences in T. cruzi are concentrated in
few large multigene families, such as MASP, mucin, TS/gp85,
mucin-like, and gp63. Of these families, mucins, TS/gp85
glycoproteins, and gp63 metalloproteinases were shown to
have important functions in the virulence and evasion/mod-
ulation of host immune response (Acosta-Serrano et al, 2007).
Although plenty of information has been obtained with the
completion of the genome project, little information is
available abouthowmanyandwhichGPI-anchoredmolecules
are expressedon the parasite surface. Thereis also a limitation
of microarray (transcriptome) and real-time PCR data for
T. cruzi gene expression, as in this organism and other
trypanosomes, protein synthesis is mostly controlled by
posttranscriptional regulation processes, like mRNA stabiliza-
tion and degradation (Jager et al, 2007). In addition,
microarray and real-time PCR analyses do not provide any
information regarding absolute or relative expression, and
structure of GPI-anchored proteins and GIPLs in different
parasite stages and strains.
Large-scale GPIomic analysis in eukaryotes is limited due to
the lack of a fast, simple, and sensitive method to characterize
GPI-anchored molecules (Ferguson, 1992; Hooper, 2001). One
of the limiting factors has been the absence of a more efﬁcient
method to purify GPIs. The current methods are based on HIC
or RPC resins and have a restricted efﬁciency, which might be
due to the amphiphilic character of these resins. Thus, we
hypothesized that using a polystyrene-divinylbenzene-based
C4 resin (e.g., POROS R1) (DePhillips et al, 1994; Whitney
et al, 1998), which is essentially hydrophobic, would increase
the chromatographic resolution of the RPC in the puriﬁcation
of GPI-anchored protein-linked and free GPIs (GIPLs). Indeed,
our results proved that our hypothesis was correct. The
resolution achieved with the POROS R1 RPC in our study was
exceptional, and we could resolve and identify a remarkable
number (90 species) of GIPLs and GPI-anchored protein-
derived GPIs.
Then, to ultimate gain sensitivity and speed, we packed
capillary columns with POROS R1 and analyzed T. cruzi
epimastigote GPIs by LC-MS
n. First, we analyzed the protein-
free GPI (GIPL) fraction. In total, we were able to identify 78
complete species of GIPLs. Of those, 70 were novel (Supple-
mentary Table I). Up to now, only a few complete species of
GIPLs had been detected and structurally characterized in
T. cruzi (de Lederkremer et al, 1990, 1991; Previato et al, 1990;
Almeida et al, 2000). Consistently, these species were also the
most abundant found in this study in the GIPL sample
extracted with 9% n-butanol.
In an earlier report, the glycan cores of GIPLs from Y strain
epimastigoteformsofT.cruziwereanalyzedbyNMR(Carreira
et al, 1996). With that approach seven different structures for
the glycan core were described. In this study, we found all
those seven glycan cores and additional ﬁve novel ones. Three
distinct series differing only in the number of hexose residues
were found ([AEP]Hex5–6-[AEP]HexN-InsP, [EtNP]Hex4–6-
[AEP]HexN-InsP, and AEP-Hex4–8-HexN-InsP) (Table I). In
addition, one minor species (comprising only 0.03% of the
totalGIPLs)withouteitherEtNPorAEP(Hex7-HexN-InsP)was
observed (Table I; Supplementary Figure 2C63). Another
minor species (0.01% of the total GIPLs) containing sialic acid
(N-acetylneuraminic acid, NANA) (NANA-Hex7-[AEP]HexN-
InsP) was also detected and characterized by MS
2 analysis
(Table I; Supplementary Figure 2C18). The presence of sialic
acid-containing glycolipids in T. cruzi was proposed earlier,
throughinvitroradiolabelingusing
3H-NANA-labeledfetuinin
epimastigote and trypomastigote cultures, but no structural
data had been provided (Confalonieri et al, 1983; Zingales
et al, 1987). Further structural and biosynthetic studies need
to be carried out to establish the detailed structure and
expression of the sialic acid-containing GIPLs in different
parasite stages. Taken together, our results clearly show a
greater diversity of GIPL species than was known
earlier, therefore, indicating a higher complexity of the GPI
biosynthesis in T. cruzi.
The analysis of proteinase K-released GPIs lead to the
characterization of 11 different species. Of those, only three
have been characterized earlier (Previato et al, 1995; Serrano
et al, 1995; Almeida et al, 2000). Most of the glycan structures
had either two AEP residues ([AEP]Hex4–5-[AEP]HexN-InsP)
or one AEP and one EtNP ([EtNP]Hex4–6-[AEP]HexN-InsP).
One species, however, had only one EtNP ([EtNP]Hex4-HexN-
InsP). Interestingly, the glycan cores containing one AEP
residue (AEP-Hex4–8-HexN-InsP) were shown to be highly
abundant in GIPLs, but they were not detected in protein-
derived GPI anchors, suggesting some differential steps during
the biosynthesis of GIPLs and GPI anchors to be attached to
proteins.
By analyzing the trypsin-released GPI-peptides, we could
determine that the mucins expressed by the epimastigote
forms of T. cruzi belong to the TcSMUG S subfamily. This
subfamily of mucins comprises few genes that encode short
polypeptides rich in Thr residues and, therefore, most likely to
be highly O-glycosylated. The only other GPI-anchored
polypeptide from epimastigotes with known amino-acid
sequence is the NETNES (Macrae et al, 2005). This molecule
has four glycosylation sites, but only 13 amino-acid residues.
We were unable to detect NETNES in our analysis, probably
due to the fact that this glycoconjugate does not have potential
sites for trypsin digestion (Macrae et al, 2005). Furthermore,
we cannot exclude that, akin to T. brucei variant surface
glycoproteins (Ferguson et al, 1988), some T. cruzi GPI-
anchored glycoproteins could not be extracted from cell
membranes with 9% n-butanol. In this case, a stronger (more
hydrophobic) extraction procedure using detergent (e.g.,
Triton X-100) should be used. This is currently under
investigation in our laboratory.
Taken together, our results and others from the literature
(Acosta-Serrano et al, 2001, 2007; Buscaglia et al, 2006)
suggest that theepimastigotecell surfaceis heavilycoatedbya
variety of GIPL structures, and to a less extent by short and
highly glycosylated GPI-anchored polypeptides. GIPLs were
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parasite with the insect midgut (Nogueira et al, 2007). The
absence of protease-cleavable polypeptide chains may also
help protecting the parasite against insect digestive enzymes.
On the other hand, bloodstream trypomastigotes were shown
to express mucins from the TcMUC II subfamily that are
composed by highly diverse sequences (Buscaglia et al, 2004).
In agreement with these earlier data, our preliminary large-
scale proteomic analysis of trypomastigotes suggests that this
mammal-dwelling forms express hundreds, perhaps thou-
sands, of GPI-anchored glycoproteins (including members of
TS/gp85, MASP, and TcMUC II families) (Nakayasu et al,
unpublished data). This high diversity of GPI-anchored
proteins in trypomastigote forms may result in the lack of
major immunodominant epitope(s) on the parasite surface,
therefore, contributing for the immunoevasion of the parasite
and its perpetuation within the mammalian host (Buscaglia
et al, 2004).
In sum, here we showed that the GPIome of epimastigote
forms of T. cruzi is highly complex. Therewere only few major
GIPL (Carreira et al, 1996; Almeida et al, 2000) and eMUC-GPI
(Previato et al, 1995; Serrano et al, 1995; Almeida et al, 2000)
species characterized earlier, and there were no o-sites
described for T. cruzi epimastigote mucins.This high complex-
ity of GIPLs and GPI-anchored proteins might be important for
theinteractionbetweentheparasiteandtheinsecthost.Thisis
the ﬁrst comprehensive study of the characterization of free
GPIs (GIPLs), protein-bound GPIs, and o sites of a eukaryotic
organism. This new methodology was shown to be simple and
highly sensitive. Our method could be used for the high
throughput screening (HTS) of potential GPI biosynthesis-
targeting drugs against pathogenic parasites (Smith et al,
2004), as well as HTS of GPI-metabolism mutant cell lines. We
also propose its use for the global analysis of the GPIome of
other pathogenic eukaryotes and mammalian cells, including
healthy and modiﬁed (cancer) cells, whose GPI anchor
structures and roles are still mostly elusive (Paulick and
Bertozzi, 2008).
Materials and methods
Prediction analysis of GPI-anchored proteins in
the T. cruzi genome
The prediction analysis was carried out using the FragAnchor
algorithm (Poisson et al, 2007) (http://navet.ics.hawaii.edu/~fragan-
chor/NNHMM/NNHMM.html) against the TcruziDB v5.0 (http://
tcruzidb.org/tcruzidb/, downloaded on August 1, 2005), T. cruzi
(downloadedon March 17, 2008)and T.brucei TREU927(downloaded
on August 13, 2008) sequences from the GenBank (http://
www.ncbi.nlm.nih.gov/sites/entrez?db¼Protein&itool¼toolbar), and
mucin TcMUC II sequences from GeneDB (http://www.genedb.org/,
downloaded on August 20, 2005). Only sequences with high
probability were accepted as potentially GPI-anchored proteins.
Solvents and salts
Otherwise indicated, all solvents and salts used in this study were of
the highest quality available (HPLC or molecular biology grade), from
Sigma-Aldrich, EMD Chemicals, or JT Baker.
T. cruzi culture
Noninfective epimastigote forms of T. cruzi (Y strain) were grown in
liver infusion tryptose medium at 281C for 3–4 days, as described
earlier (Camargo, 1964). Cells were harvested and washed twice in
phosphate-buffered saline (PBS), pH 7.4, and centrifuged at 2000g at
41C for 10min. The parasite pellet containing 3.6 10
10 was then store
at  201C until use.
Extraction of free GPIs and GPI-anchored proteins
The parasite pellet (3.6 10
10 cells) was placed in an ice-bath,
resuspended in 2ml HPLC-grade water, and immediately transferred
to a 15-ml PTFE-lined, screw capped glass tube (Supelco). Then,
methanol, chloroform, and water were added to give 15ml of the
mixture chloroform:methanol:water (1:2:0.8, v:v:v). After homogeni-
zation in vortex (1min), the suspension was centrifuged for 20min at
2000g. The organic phase was removed and transferred to a 100-ml
glass ﬂask, and the pellet was extracted three times with 10ml
chloroform:methanol (C:M, 2:1, v/v) solution, and twice with 10ml
chloroform:methanol:water (C:M:W, 1:2:0.8,v/v/v) solution. Between
extractions, the organic phase was separated from the pellet by
centrifugationat2000g for 20min,atroomtemperature,andsaved.All
organic phases were combined, dried under N2 stream, and the
resulting organic extract was subjected to Folch’s partition (Folch et al,
1957). The upper (aq.) phase of the partition, rich in free GPIs (GIPLs),
wasdriedunderN2streamandanalyzedbyLC-MS
2asdescribedbelow.
The resulting delipidated parasite pellet was dried under N2 stream
and extracted 3  with 4ml 9% n-butanol, essentially as described
(Almeida et al, 2000). The GPI-anchored proteins were separated from
residual GIPLs by n-butanol:water (1:1, v/v) partition. The aq. phase,
enriched with GPI-anchored proteins, was dried in a vacuum
centrifuge (Vacufuge, Eppendorf) and stored at  201C until use.
Biotinylation of epimastigote mucins and CLA
Epimastigote mucins were extracted and puriﬁed using octyl-
Sepharose column (GE Healthcare), as described (Almeida et al,
2000). For biotinylation, the mucin sample was dried in a vacuum
centrifuge, redissolved in 1ml PBS containing 1mM NHS-biotin
(Pierce), and incubated for 2h in an ice bath. The reaction was
terminated by the addition of Tris–HCl pH 8.8 to a 50-mM ﬁnal
concentration, and the sample was dialyzed for 24h against MilliQ
ultrapure water (Millipore), at 41C. The labeling efﬁciency was
monitored by CLA. Brieﬂy, biotinylated mucins were diluted 10-fold
in 50mM carbonate-bicarbonate buffer pH 9.6, immobilized on
polystyrene 96-well chemiluminescent ELISA microplate (Nunc,
Invitrogen) and incubated overnight at 41C. After blocking for 2h at
371C with PBS-0.1% bovine serum albumin (PBS-A), 50ml horse-
radish-conjugated streptavidin (1:1000 dilution) (Invitrogen) in PBS-A
was added. The plate was washed 3  with PBS containing 0.1%
Tween-20(PBS-T)anddevelopedwith50mlchemiluminescentreagent
(SuperSignal, Pierce) diluted ﬁve-fold in 200mM carbonate/bicarbo-
nate buffer, pH 9.6. Chemiluminescent readings were measured in a
luminometer (Luminoskan Ascent, Labsystems, Finland).
Puriﬁcation of synthetic GPIs
T. cruzi epimastigote and trypomastigote GPIs were synthesized as
described earlier (Yashunsky et al, 2006) and stored as NMR samples
in [
2H]6-DMSO solution. Synthetic GPI samples were puriﬁed (from
by-products appeared during storage) in reverse phase ziptips, built in
200-ml micropipette tips with a small piece of glass-ﬁberﬁlterand 50ml
40mg/ml POROS R1 (C4) 50 resin (50-mm average particle size,
Applied Biosystems) (Whitney et al, 1998) in 2-propanol. The ziptips
were washed with 100ml methanol and equilibrated with 5%
2-propanol/10mM ammonium acetate (AA). About 1nmol of syn-
theticGPI sample,containingseveral by-products,wasresuspended in
100 ml of 5% 2-propanol/10mM AA and after loading, the column was
washed with the same buffer, followed by step-wise elution of
increasing concentration (10–90%) of 100ml2 - p r o p a n o lc o n t a i n i n g
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sample with 5% n-propanol and eluting with 80% n-propanol. The
fractionsweredriedinavacuumcentrifugeandstoredat 201Cuntiluse.
Puriﬁcation of GPI-anchored proteins from T. cruzi
epimastigote extracts
Extracted GPI-anchored proteins from epimastigote forms were
puriﬁed in POROS R1 solid-phase cartridges. The cartridges were
assembled in solid-phase extraction supports with 1ml POROS resin
(40mg/ml in 2-propanol). A glass ﬁber ﬁlter was laid over the resin
bed to avoid disturbance during the sample loading and elution steps.
The cartridge was washed with 4ml 2-propanol and 4ml methanol
before being equilibrated with 4ml 5% n-propanol. The puriﬁed
mucin sample was redissolved in 5% n-propanol and spiked with
biotinylated epimastigote mucins. After loading onto the cartridges,
samples were eluted in increasing concentration (5, 10, 12.5, 15, 17.5,
20, 22.5, 25, 27.5, 30, 50, and 90%) of n-propanol. The fractions were
dried in a vacuum centrifuge and analyzed by SDS–PAGE (Laemmli,
1970) stainedwithsilver(Mortzet al, 2001),and byCLAas above.The
bands from the gel were excised, digested with trypsin, and sequenced
by LC-MS
2 (see below).
Protease digestion of GPI-anchored proteins
GPI-anchored proteins extracted with 9% butanol from the equivalent
to 1.8 10
9 parasites (approximately 200mg of total protein) were
digested overnight at 371C with 50mg proteinase K (from Tritirachium
album, lyophilized powder, X30 units/mg protein, Sigma) or 2mg
sequencing-grade trypsin (Promega) in 100mM ammonium bicarbo-
nate, pH 8.0. The digested GPI samples were repuriﬁed in POROS R1
ziptips, as described above, and analyzed directly by ESI-MS
2 using a
Qtof-1 ESI-MS, or LC-MS
n using a LTQXL ESI-linear ion trap-MS.
ESI-MS
2 analysis of GPI samples
Synthetic and puriﬁed GPI samples were resuspended in 50%
n-propanol/10mM AA and injected by infusion (500nl/min) into an
ESI-QTOF-MS (Qtof-1, Micromass, Waters). Spectra were collected in
the negative-ion mode at 50–2000 mass-to-charge (m/z) range. The
nanospray source was set at 1.5–2.5kV, cone voltage 35V, and the
source and desolvation temperatures at 110 and 1501C, respectively.
Each GPI species was subjected to fragmentation with collision energy
from 30 to 50eV.
LC-MS
n analysis of GPI samples
Capillary columns (75-mm internal diameter by 10-cm length) were
packed with 10mg/ml POROS R110 resin (10-mm particlesize; Applied
Biosystems) (suspension in 100% acetonitrile (ACN)) with a high-
pressure apparatus at 500psi (Gatlin et al, 1998). The quality of
packing was monitored in a stereomicroscope. GPI samples were
redissolved in 20% 2-propanol/0.2% FA and loaded onto the capillary
column connected to a nanoHPLC system (1D-Plus, Eksigent). The
samples were eluted in a gradient of 20–80% solvent B over 60min
(solventA:5%2-propanol/0.2%FA;solventB:90%2-propanol/0.2%
FA) and directly analyzed in the linear ion-trap mass spectrometer
(LTQ XL, Thermo Fisher Scientiﬁc). To compensate eventual decrease
in the ﬂow rate at high concentrations of organic solvent, the ﬂow rate
was set as a gradient from 350 to 450nl/min within the same period of
time. The ionization source was set to 1.9kVand 2001C. The full MS
scanwas collected in positivemode from400 to 2000 m/z rangewith a
maximum injection time of 100ms. The ﬁve most intense ions were
submitted to fragmentationwith 40% normalized collisionenergyand
a maximum injection time of 150ms. When the dynamic exclusion
function was enabled, it was set to collect only twice and then to
exclude for 30s. Totest the sensitivityof the method,the sampleswere
also analyzed by the MRM approach. For this analysis, parent ions at
m/z 911 and 919, which correspond to the major species of T. cruzi
epimastigote mucin GPIs (Almeida et al, 2000), were constantly
selected and fragmented. In addition, to determine the structure of
lipid tail or the small peptide sequence attached to the GPI, these
fragments were analyzed by MRM/MS
3. All the spectra were analyzed
manually to assign the GPI structures.
Determination of retention times and relative
quantiﬁcation of GPI species
To determine the retention times, individual parent ions were plotted
as extracted-ion chromatograms. The peaks were smoothed 13 times
with the Gaussian method. The retention times were annotated as the
top of individual peaks.
To standardize the quantitative analysis, synthetic GPIs [Man-
[EtNP]Man-Man2-[AEP]GlcN-InsP-1-O-alkyl-C16:0-2-O-acyl-C16:0-
Gro (sGPI-C16:0), Man-[EtNP]Man-Man2-[AEP]GlcN-InsP-1-O-alkyl-
C16:0-2-O-acyl-C18:2-Gro (sGPI-C18:2), Man-[EtNP]Man-Man2-
[AEP]GlcN-InsP-1-O-alkyl-C16:0-2-O-acyl-C18:1-Gro (sGPI-C18:1)]
were mixed in different ratios in 50% 2-propanol, 0.2% FA and
analyzed in a linear ion-trap mass spectrometer (LTQXL, Thermo
Fisher Scientiﬁc). The samples were injected with an automated
system (Triversa Nanomate, Advion), set at 1.5kV and 0.25 p.s.i. N2
pressure, to avoid cross-contamination between samples. Full
(enhanced scan rate, 100ms maximum injection time) or MS
2 (normal
scan rate, 3 a.m.u. isolation width, 35% normalized collision energy)
scans were collected for 20s. Each sample was run in triplicates. The
relative quantiﬁcation of the GPI species was done by the MS
2 TIC
(Asara et al, 2008).
Identiﬁcation of proteins separated by SDS–PAGE
The protein bands from the SDS–PAGE were excised and digested as
described earlier (Shevchenko et al, 1996). The resulting peptides were
puriﬁedinPOROSR2ziptips,asdescribedelsewhere(Juradoetal,2007).
Resulting peptides were loaded into a capillary reverse phase column
(PepMap, C18 3mm, 15cm 75mm, LC Packings, Dionex) connected to
anUltimatenanoHPLC(LCPackings,Dionex)intandemtoanESI-QTOF-
MS. The elution was performed with a ﬂow rate of 300nl/min in a
gradient of 5–35% ACN/0.1% FA in 25min, 35–72% ACN in 1min, and
hold at 72% ACN for 5min. MS spectra in positive-ion mode were
collected in the 400–1800 m/z range, and each peptide was fragmented
(MS
2)for3sinthe50–2050m/zrange.MSdatawereconvertedintopeak
lists (PKL format) and searched against TcruziDB v5.0 (Aguero et al,
2006) (http://tcruzidb.org) using Mascot algorithm (Perkins et al, 1999)
(Matrix Science). Database search parameters were the following:
trypsin as the digesting enzyme (one missed cleavage site allowed);
500ppm for peptide mass tolerance for monoisotopic ion; 0.8Da for
fragment mass tolerance; and carbamidomethylation of cysteine
residues and oxidation of methionine residues as ﬁxed and variable
modiﬁcations, respectively. We validated only proteins with Po0.05,
according tothe software. An ion-score cutoffof 20 was set toensure the
quality of valid peptides and to remove redundant protein hits. Spectra
with no peptide matching were subjected to de novo sequencing using
PepSeq tool from the MassLynx v4.0 software (Waters).
Quantiﬁcation of myo-inositol content by GC-MS
The myo-inositol content in the sample was determined as described
(Ferguson, 1992). Brieﬂy, 20pmol of scyllo-inositol (Sigma) internal
standardwasaddedtoeachsampleinaheat-cleaned(5001C,2h),one-
end ﬂame-sealed borosilicate 250-ml capillary microtube. An external
standard containing 20pmol of myo-inositol (Sigma) and 20pmol of
scyllo-inositol was also prepared. Samples were dried and subjected to
strong acid hydrolysis with 50ml of 6M constant boiling HCl at 1101C
for 24h. The products were dried, redried on 20-ml methanol addition,
and derivatized for 30min with 15ml freshly made trimethylsilyl
(TMS) reagent (hexamethyldisilazane:trimethylchlorosilane:pyridine,
15:5:100, v:v:v). The inositol-TMS derivatives were analyzed on a
TRACEGCUltragaschromatographysystemlinkedtoaPolarisQmass
spectrometer (GC–MS, Thermo Fisher Scientiﬁc) using a Supelco
SP2380t column (30m 0.25mm ID 0.25mm). The initial oven
temperaturewassetto1001Cfor3minandthenagradientof151C/min
up to 2501C was applied. The ﬁnal temperature of 2501C was kept for
5min. The splitless injector was held at 2001C, the MS transfer line at
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chromatogram for myo-inositol was plotted using the diagnostic
fragment ions at m/z 305 and 318. For the myo-inositol quantiﬁcation,
the chromatogram peaks were integrated and the following formula
was applied: [area sample myo peak/area scyllo internal standard
peak] [amount of internal standard/(area standard myo peak/area
standard scyllo peak)].
Supplementary information
Supplementaryinformationisavailableat theMolecular Systems Biology
website (www.nature.com/msb). Raw data ﬁles of LC-MS and GPI-
predictionanalysesareavailablefromtheProteomeCommonsrepository
(dataset at https://proteomecommons.org/dataset.jsp?i=72069).
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